Theravance Biopharma (TBPH) Change in Inventory (2013 - 2018)

Theravance Biopharma (TBPH) has 6 years of Change in Inventory data on file, last reported at $1.1 million in Q4 2018.

• Change in Inventory for Q4 2018 came in at $1.1 million, down 75.17% year-over-year; the trailing twelve-month figure through Dec 2018 was $1.6 million (down 77.69% YoY), and the FY2018 annual result was $1.6 million, down 77.69% from the prior year.
• Change in Inventory advanced to $1.1 million in Q4 2018 per TBPH's latest filing, from $201000.0 in the prior quarter.
• Over five years, Change in Inventory peaked at $4.3 million in Q4 2017 and troughed at -$912000.0 in Q4 2015.
• A 5-year average of $885500.0 and a median of $306000.0 in 2015 frame the typical range for Change in Inventory.
• The sharpest annual moves came in 2014 and 2015: Change in Inventory jumped 7096.15% in 2014, then sank 542.72% in 2015.
• A 5-year view of Change in Inventory shows it stood at $206000.0 in 2014, then slumped by 542.72% to -$912000.0 in 2015, then jumped by 247.37% to $1.3 million in 2016, then soared by 222.77% to $4.3 million in 2017, then slumped by 75.17% to $1.1 million in 2018.
• Business Quant data shows TBPH's Change in Inventory at $1.1 million in Q4 2018, $201000.0 in Q3 2018, and -$20000.0 in Q2 2018.